
    
      Thirty-two children with growth hormone (GH) deficiency (25 males, mean age 10.5 Â± 2.2 yr)
      were randomly assigned to receive daily (group A, No 16) or three injections per week (group
      B, No 16) GH therapy for 12 months.

      Auxological parameters, insulin-like growth factor-I (IGF-I), glucose and insulin during an
      oral glucose tolerance test, glycosylated hemoglobin, lipid profile, the oral disposition
      index (DIo), the homeostasis model assessment estimate of insulin resistance (Homa-IR), the
      quantitative insulin sensitivity check index (QUICKI) and the insulin sensitivity index (ISI)
      were evaluated in the two groups of patients.
    
  